By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Candida albicans skin test antigen (monograph)
Drugs

Candida albicans skin test antigen (monograph)

https://themeditary.com/drug/candida-albicans-skin-test-antigen-monograph-8297.html
Medically Reviewed by Oluni Odunlami, MD TheMediTary.Com | Reviewed: Aug 23, 2023  Additional Content by TheMediTary.Com

Generic name: introduction

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Candida albicans skin test antigen (monograph)?

Warning

  • The expected response to candida albicans skin test antigen is a local area of inflammation at the site of the skin test. The size of reaction depends upon the sensitivity of the person receiving the test, but is usually dime to quarter size reaching maximum diameter between 24 and 48 hours. Larger accelerated reactions can occur, which may require treatment with local cold compresses and anti-inflammatory medication.

  • Systemic reactions can occur with skin test antigens and in certain individuals these reactions may be life-threatening or cause death. Emergency measures as well as personnel trained in their use should be immediately available in the event of a life-threatening reaction. Patients should be observed for at least 20 minutes following the administration of a skin test.

  • Candida albicans skin test antigen should never be given intravenously.

  • Serious adverse reactions to Candida albicans skin test antigen should be reported to Nielsen BioSciences, Inc. at (855) 855-1212 or MEDWATCH, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20852-9782. Telephone: (800) 332-1088 or [Web].

Introduction

Antigen preparation derived from culture filtrate and cells of Candida albicans.

Uses for Candida Albicans Skin Test Antigen

Cellular Hypersensitivity

Used as a recall antigen for detecting cell-mediated hypersensitivity to Candida albicans.

May be used to evaluate the cellular immune response in patients suspected of having reduced cellular hypersensitivity.

Some individuals with normal cellular immunity may not be hypersensitive to Candida; therefore, concurrent use of other licensed cell-mediated hypersensitivity skin test antigens is recommended.

HIV infection can modify the delayed-type hypersensitivity (DTH) response to tuberculin; therefore, it is advised to test HIV-infected patients at high risk of tuberculosis with antigens in addition to tuberculin.

Do not use to diagnose or treat Type 1 allergy to Candida albicans.

Candida Albicans Skin Test Antigen Dosage and Administration

General

Patient Monitoring

  • Observe patients for at least 20 minutes following administration of the skin test.

Dispensing and Administration Precautions

  • Systemic reactions can occur with skin test antigens and in certain individuals these reactions may be life-threatening or fatal. Emergency measures, equipment, and personnel including epinephrine and oxygen should be immediately available when administering candida albicans skin test antigen.

  • The expected response is a local area of inflammation at the site of the skin test. The reaction is usually dime to quarter size reaching maximum diameter between 24 and 48 hours. Larger accelerated reactions can occur, which may require treatment with local cold compresses and anti-inflammatory medication.

Administration

Administer intradermally; do not inject IV. Take care to avoid injection into a blood vessel.

Administer intradermal injections into volar surface of forearm or outer aspect of upper arm. Must administer as superficially as possible causing a distinct, sharply defined bleb. An unreliable reaction may result if the product is injected sub-Q.

Clean skin with 70% alcohol before applying the skin test.

Dosage

Adults

Cellular Hypersensitivity
Intradermal Injection

Dose used to assess cellular hypersensitivity is 0.1 mL.

Time required for the induration response to reach maximum intensity varies. The reaction usually begins within 24 hours and peaks between 24 and 48 hours.

Read the skin test at 48 hours by visually inspecting the test site and palpating the indurated area. An induration ≥5 mm is considered to be a positive delayed-type hypersensitivity (DTH) reaction.

Detailed Candida albicans extract dosage information

Warnings

Contraindications

  • Previous unacceptable adverse reaction (e.g., extreme hypersensitivity or allergy) to the antigen contained in candida albicans skin test antigen or to a similar product.

Warnings/Precautions

Warnings

Serious Adverse Reactions

Larger reactions other than the expected local response may occur following administration of skin test. (See Boxed Warning.)

Life-threatening or fatal systemic reactions may occur. Report serious adverse reactions to the manufacturer or FDA.

Administration Precautions

Candida albicans skin test antigen must be injected intradermally as superficially as possible, causing a distinct, sharply defined bleb at the skin test site. An unreliable reaction may result if the product is injected sub-Q. Must not administer IV; take care to avoid injecting into a blood vessel.

Use a separate sterile syringe and needle for each patient to prevent transmission of infectious agents. Dispose of needles properly and do not recap.

Ensure that facilities, equipment, and medication (epinephrine, oxygen) necessary to treat potential adverse effects are readily available.

Do not administer IV. (see Boxed Warning.)

Local and Systemic Reactions

As with all skin test antigens, local and systemic allergic reactions can occur.

Local reactions include swelling, pruritus, and vesiculation. Necrosis and ulceration not observed, but theoretically possible. Local reactions may be treated with a cold compress and topical steroids. Severe local reactions (e.g., rash, vesiculation, bullae, dermal exfoliation, cellulitis) are possible in highly allergic persons; may require additional measures as appropriate.

In individuals with a bleeding tendency, trauma from the skin test may cause bruising and nonspecific induration.

Local immediate hypersensitivity reactions may occur. Such reactions are characterized by edematous hive surrounded by a zone of erythema and observed approximately 15–20 minutes after intradermal injection.

Systemic reactions not observed, but possible. Systemic reactions usually occur within 30 minutes after injection of antigen and may include the following symptoms: sneezing, coughing, itching, shortness of breath, abdominal cramps, vomiting, diarrhea, tachycardia, hypotension, and respiratory failure in severe cases.

Systemic allergic reactions (e.g., anaphylaxis) must be immediately treated with epinephrine HCl 1:1,000. Additional measures may be required, depending on severity.

Specific Populations

Pregnancy

Not known whether candida albicans skin test antigen can cause fetal harm or affect reproductive capacity. Animal reproduction studies not conducted. Use in pregnant women only if clearly needed.

Lactation

Not known whether candida albicans skin test antigen is excreted in human milk. Exercise caution when administering to a nursing woman.

Pediatric Use

Safety and effectiveness not established in children. However, the skin test has been used in pediatric patients for assessing cellular immunity.

Geriatric Use

Not adequately studied in geriatic patients; however, such patients may have a diminished response since the aging process is known to alter cell-mediated immunity.

Common Adverse Effects

Immediate hypersensitivity local reactions can include itching, swelling, pain, and blistering at the test site occurring 15-20 minutes after administration. Necrosis is possible.

Systemic reactions not observed; however, all foreign antigens have the remote possibility of causing Type 1 anaphylaxis and even death when injected intradermally.

How should I use Candida albicans skin test antigen (monograph)

General

Patient Monitoring

  • Observe patients for at least 20 minutes following administration of the skin test.

Dispensing and Administration Precautions

  • Systemic reactions can occur with skin test antigens and in certain individuals these reactions may be life-threatening or fatal. Emergency measures, equipment, and personnel including epinephrine and oxygen should be immediately available when administering candida albicans skin test antigen.

  • The expected response is a local area of inflammation at the site of the skin test. The reaction is usually dime to quarter size reaching maximum diameter between 24 and 48 hours. Larger accelerated reactions can occur, which may require treatment with local cold compresses and anti-inflammatory medication.

Administration

Administer intradermally; do not inject IV. Take care to avoid injection into a blood vessel.

Administer intradermal injections into volar surface of forearm or outer aspect of upper arm. Must administer as superficially as possible causing a distinct, sharply defined bleb. An unreliable reaction may result if the product is injected sub-Q.

Clean skin with 70% alcohol before applying the skin test.

Dosage

Adults

Cellular Hypersensitivity
Intradermal Injection

Dose used to assess cellular hypersensitivity is 0.1 mL.

Time required for the induration response to reach maximum intensity varies. The reaction usually begins within 24 hours and peaks between 24 and 48 hours.

Read the skin test at 48 hours by visually inspecting the test site and palpating the indurated area. An induration ≥5 mm is considered to be a positive delayed-type hypersensitivity (DTH) reaction.

Detailed Candida albicans extract dosage information
Candida albicans skin test antigen (monograph) Dosage information (more detail)

What other drugs will affect Candida albicans skin test antigen (monograph)?

Corticosteroids and Immunosuppressive Drugs

Pharmacologic doses of corticosteroids may suppress the DTH skin test response after 2 weeks of therapy. Response usually returns to pretreatment level within several weeks after steroid therapy is discontinued.

Beta-blocking Drugs

Patients receiving beta-blocking drugs may not respond to usual doses of epinephrine, in the event that epinephrine is required to control an adverse allergic reaction.

More about Candida albicans skin test antigen (monograph) (Introduction)

Dosage information
Candida albicans skin test antigen (monograph) Side Effects
During pregnancy
Drug images
Side effects
Drug class: Drugs
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by